Latest News & Updates
Breaking News
2 hours ago
Simantini Singh Deo
Other trending news you may like to read
Ovid Therapeutics Appoints Dr. Petra Kaufmann As Chief Medical Officer To Lead Clinical And Regulatory Strategy For CNS Therapies
Ovid Therapeutics appoints Dr. Petra Kaufmann as CMO to lead clinical and regulatory strategy for its CNS pipeline, including OV329 and KCC2 activators.
Simantini Singh Deo
Palisade Bio Appoints Dr. James Izanec As Vice President Of Clinical Development To Strengthen Its Clinical Leadership Team
Palisade Bio appoints Dr. James Izanec as VP of Clinical Development, strengthening late-stage trial leadership for its oral PDE4 inhibitor pipeline.
Simantini Singh Deo
20251204103208.png)
Longeveron Secures Canadian Patent For LOMECEL-B Use In Treating Aging Frailty And Non-Ischemic Dilated Cardiomyopathy, Secures Protection Until 2037
Longeveron secures a Canadian patent for laromestrocel, strengthening IP protection for its MSC therapy in aging-related frailty and NIDCM.
Simantini Singh Deo
ADARx Pharmaceuticals Appoints Industry Veteran Dr. Mary Tagliaferri To Board Of Directors To Support Growth Of Its RNA Therapeutics Pipeline
ADARx adds industry veteran Dr. Mary Tagliaferri to its Board, strengthening leadership as the company advances its RNA-based therapeutics pipeline.
Simantini Singh Deo
